[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].
Giordano Madeddu(University of Sassari), Paolo Bonfanti(University of California San Diego), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio), Loredana Palvarini, Giuseppe Vittorio De Socio(University of Perugia), Elena Ricci(Mario Negri Institute for Pharmacological Research), E Rossella, María Stella Mura, Giovanni Penco(Ente Ospedaliero Ospedali Galliera), Sara Melzi(Luigi Sacco Hospital), Patrizia Marconi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Carmela Grosso(Azienda-Unita' Sanitaria Locale Di Cesena), Silvia Carradori(Azienda Ospedaliero-Universitaria Careggi)
PubMed
September 1, 2006
Cited by 9
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
|medRxiv|2020|234
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208